Login / Signup
Nithya Ramnath
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 3
Top Topics
Epithelial Mesenchymal Transition
High Dose
Mouse Model
Idiopathic Pulmonary Fibrosis
Top Venues
Translational lung cancer research
Molecular cancer research : MCR
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Julie Moeller
,
Michael D Green
,
Nithya Ramnath
Pros and cons of subcutaneous (SC) versus intravenous (IV) administration of immune checkpoint inhibitors in non-small cell lung cancer.
Translational lung cancer research
13 (6) (2024)
Julie Moeller
,
Michael D Green
,
Nithya Ramnath
Pros and cons of subcutaneous (SC) versus intravenous (IV) administration of immune checkpoint inhibitors in non-small cell lung cancer.
Translational lung cancer research
13 (6) (2024)
Ivana Barravecchia
,
Jennifer M Lee
,
Jason Manassa
,
Brian R Magnuson
,
Sarah F Ferris
,
Sophia Cavanaugh
,
Nina G Steele
,
Carlos E Espinoza
,
Craig J Galban
,
Nithya Ramnath
,
Timothy L Frankel
,
Marina Pasca Di Magliano
,
Stefanie Galban
Modeling Molecular Pathogenesis of Idiopathic Pulmonary Fibrosis-Associated Lung Cancer in Mice.
Molecular cancer research : MCR
(2023)